TRP_1170x120_3-8-19

AMP

Rx takes hard look at long-awaited Medicaid AMP rule

Rx takes hard look at long-awaited Medicaid AMP rule

ARLINGTON, Va. — The National Association of Chain Drug Stores was working with member companies at presstime to review the final rule on Medicaid prescription reimbursements. The Centers for Medicare & Medicaid Services (CMS) says the 658-page rule — which takes effect April 1 after a comment period — establishes a regulatory definition for average

AMP issue illustrates the pressure on Rx

AMP issue illustrates the pressure on Rx

After years of political and legal wrangling, the Centers for Medicare & Medicaid Services (CMS) has issued its final rule on Covered Outpatient Drugs, which governs reimbursement to retail pharmacies for generic medications dispensed under Medicaid. The history of the regulation goes all the way back to the Deficit Reduction Act of 2005 (DRA), which

Right on top of AMP issue

Right on top of AMP issue

The National Association of Chain Drug Stores is on top of it, says president and CEO Steve Anderson. Anderson is talking, of course, about the Centers for Medicare & Medicaid Services issuance last week of the final rule for Covered Outpatient Drugs, which augurs key changes for Medicaid pharmacy reimbursement for generic drugs based on

Industry eyes CMS final rule for Rx reimbursement

Industry eyes CMS final rule for Rx reimbursement

WASHINGTON — The Centers for Medicare & Medicaid Services (CMS) has issued the Covered Outpatient Drugs final rule with comment, which the National Association of Chain Drug Stores said includes “significant changes” to Medicaid pharmacy reimbursement for generic drugs based on the average manufacturer price (AMP) model. Released on Thursday and due to be published